Oncology office seeks director
This article was originally published in The Gray Sheet
Executive Summary
FDA is searching for a director of the newly formed Office of Oncology Drug Products. The agency is targeting candidates "outside as well as from inside the government," Acting Commissioner Lester Crawford states at an Aug. 2 National Press Club luncheon in Washington, D.C. Crawford called the job "appealing," and told the audience that the director would "be able to define this exciting new position." The new division will combine current review divisions for imaging agents, biologics and oncology drugs. The hire likely will coincide with a new, formal partnership with the National Cancer Institute (1"The Gray Sheet" July 19, 2004, In Brief)...